, , , , ,

Preliminary results of transdermal "quantum SIM-medicines" clinical tests

Theses of the report "Preliminary results of transdermal "quantum SIM-medicines" clinical tests"

DPhil, professor, USSR state prize-winner, academician of Moscow Institute of Aviation S. Yakubovich, DPhil, academician of Moscow Institute of Aviation A. Khesin (Samara Branch)

One of the peculiarities of modern medicine, particularly in the last quarter of the XX century, is constant emerging of new treatment methods. Most pharmaceuticals, used in today's medical practice, contain highly toxic ingredients, which as a rule results in adverse reaction to the medicines used. Pernicious delayed consequences for organism immune system hide also in prescription of immunomodulators, which are used by any doctor, who faces the necessity to cure chronic or system patalogical process. And finally, we can't ignore the rising resistance of wide range of infectious diseases causative agents to traditional medicines effect. The latest research, concerning the pathogenic effect of some popular medicines in the therapeutic practice makes doctors fear, in many cases, to use the medicines, which have no substitutes our pharmaceutical industry can offer. The circumstances, stated above, makes it more acute to search for highly effective, totally new medical and preventive means, free from the adverse toxic effect on the organism, which do not contribute to the development of resistance in the population environment of infection. One of such means can become "quantum SIM-medicines", created on the basis of developments in the quantum physics sphere and achievements of advanced defense industry.

"Quantum SIM-medicines" are a result collective work of scientists and specialists team from defense industry and partner companies in the sphere of electronics and nuclear physics, in the network of scientific direction "Living machines", which lasted many years. The research work was carried out on the basis of Central Devices Construction Bureau (CDCB), the head enterprise of the USSR, producing medical and specialized equipment. (The head of the enterprise is professor S. Yakubovich, USSR state prize winner, academician of Moscow Institute of Aviation, as well as of state manufacturing enterprise "Plant named after Maslennikov".)

In the early 1990-es ondulator altiintellectual system "SOFIGUR" and a range of devices, having a wide therapeutical effect, were created on the basis of nano-computer technologies. The preliminary clinical tests showed their high medical efficiency, and also determined the further developments in the direction of specialized devices with narrow directional effect similar to some pharmaceuticals, rather than versatile ones. The transdermal "quantum SIM-medicine" of physiotherapeutic effect, shown at the presentation "High Technologies in Russia", in the "News" printing agency, meets these requirements. (Moscow, March of 1992).

The "quantum SIM-medicine" should be taken uninvasively making use of special transdermal injector, which is a versatile physiotherapeutic device with changeable elements - SIM-cards (of quantum medicines). Specialized SIM-card crystals bear a programme, regulating tarnsdermal injector light flux radiation. Each SIM-card is a most sophisticated nano-controller, whose memory contains effect operator of a specific pharmaceutical, EGPROM system modules packed by doses. When using a quantum medicine, the operators provide medical effect on the human organism like conventional pharmaceuticals. Changing SIM-card in the injector is similar to changing a medicine. An automated system of human organism diagnostics, based on the well-known in medicine "Khesin's principle" built in the controller, enables nano-controller to estimate at initial stage of an illness the state of the organism at the cell level, make a decision of using a quantum medicine to achieve remission and eliminate the foci of patalogy. System software, called "Artificial intelligence", allows nano-controller to generate by itself software products, necessary for dynamical performance of its functional tasks, taking into consideration the genetic peculiarities of a patient. Measuring medicine at target-cells is regulates naturally, with the help of resonance principle, well-known in EHF-therapy, where due to radiation resonance peak sharpness, only those cells with abnormalities of their functions are affected, at the same time reaction from the healthy ones is absent. The peculiarities of resonance interaction with normal and patalogical cells and biological feedback provide additional protection from "quantum SIM-medicine" overdosing. Injection is made by transdermal injector modulated light flux effect on acupunctural points of the body, Zakharyin-Gedd zone, sore organ projection or pain syndrome area.

At the model level for transdermal taking method, there was created a number of quantum medicines similar by their function to corresponding pharmaceuticals in the name:

  • -INSULIN Therapeutic indications are as follows: treatment of pancreatic diabetes, general exhausting, coronary insufficiency, gastrointestinal disturbances, hepatitis, initial forms of liver cirrhosis.
  • -ZOVIR Therapeutic indications are as follows: treatment of recurrent herpetic skin and mucous membrane lesions, cytomegalovirus disease, prevention of virus infections in radiation damage conditions, leukaemias, HIV, organs and tissues transplantation.
  • -V ZAPROSTAN Therapeutic indications are as follows: treatment of chronic obliterating arterial diseases at III and IV stages, varicocele, chronic fatigue syndrome.
  • -INSUMAN Therapeutic indications are as follows: treatment of pancreatic diabetes, general exhausting, thyrotoxicosis, gastrointestinal disturbances, hepatitis, liver cirrhosis.
  • -VOLTAREN Therapeutic indications are as follows: ch ronic rheumatic heart diseases, musculoskeletal system and connective tissues diseases, rheumatoid arthritis, arthrosis, podagra, neuralgia, myositis, injuries.
  • -GRANOCYTE Therapeutic indications are as follows: leucopenia, leukemia, hard infections, neoplasms oncology after radio- and chemotherapy.
  • -CORDYCEPS Therapeutic indications are as follows: disseminated sclerosis, nervous exhaustion, cardiac and renal insufficiency, chronic fatigue, vessels sclerosis, premature aging, CHD.
  • -DIFLUCAN Therapeutic indications are as follows: treatment of candidal peritoneum infections, endocardium, eyes, respiratory and urinary tracts, mouth, gullet, esophagus mucous membranes, HIV, deep mycoses, meningitis.

Transdermal "quantum SIM-medicines" are immune to any environmental impacts, includind radiation, and preserve their medical quality during ten years since being produced. The number of doses in the quantum medicine SIM-card is varies from 10 to 100. each SIM-card has a sophisticated authentication and cryptographic protection system, excluding the possibility of falsification. Comparatively low net cost and the possibility of replication in large volumes will provide "quantum SIM-medicines" being widely available in medical practice. Research of "quantum SIM-medicines" since 1990 brought wide scientific and practical experience in studying their unique characteristics and rational behaviour.

One of the many investigation purposes was the estimate of the new medicamentous method counterpart efficiency in complex treatment of patients with different nosology. This new method is the uninvasive quantum therapy making use of quantum SIM-medicines. 2436 volunteers of different ages, varying from 19 to 77, were observed. The basis for diagnoses was clinical and biochemical data and conventional methods of hardware clinical diagnostics. Duration of the illness varied from 1 to 10 years. In accordance with the method, 50% of patients were given medicamentous therapy based on pharmaceuticals, the rest of the patients beside this took the therapy using quantum SIM-medicines, similar in their effect to the prescribed pharmaceuticals.

The therapeutic indication for taking quantum SIM-medicines was ineffectiveness of conventional therapy or side effects of pharmaceuticals effect expressed in general intoxication, allergy, depression, changing the blood formula, emerging of autoimmune antibodies and etc. Taking into account such choice of the research participants, the placebo effect was objectively minimized.

The clinical basis for carrying out preliminary research of "quantum SIM-medicines" effect were the following medical institutions: Medical University of Kursk, the medical unit of Kursk nuclear power plant, the environmental safety unit of Kursk nuclear power plant, Belgorod ambulance hospital 1, Karochansk regional hospital of Belgorod region, city clinical hospital 9 named after Speranskiy in Moscow, medical unit of Gubkin, Staryi Oskol clinical hospital, Samara clinical hospital.

The estimate of the therapy efficiency was made according to the data of physical examination, physiological, clinical and laboratory indexes and other conventional diagnostics methods, which medical institutions, carrying out the test of quantum SIM-medicines, had in their disposal.

Here is a summery table of trancdermal method of complex treatment clinical approbation results of complex treatment trancdermal method by "quantum SIM-medicines" being counterparts of pharmaceuticals.


Nosology

Total

Remission

Arthritis

26

26

Arthrosis

20

17

Ishemic heart desease

8

6

Senile prediabetes

18

18

Pancreatic diabetes (insulin independent)

22

21

Pancreatic diabetes (insulin dependent)

36

32

Enteritis

8

3

Diabetic angiopathy

12

7

Hepatitis

8

8

Liver cirrhosis (initial stage)

12

7

Shmorl ruptures

3

3

Cerebral atherosclerosis

18

18

Disseminated sclerosis

3

3

Side ameotrophic sclerosis

5

5

Essential hypertension II stage

70

70

Essential hypertension III stage

60

53

Essential hypertension IV stage

45

30

Neurasthenia

36

30

Radiation disease

7

7

Vegetative disturbances

10

10

Crohn's disease

5

5

Bechterew's disease

2

2

Acute respiratory diseases

125

125

Neuralgia

12

12

Myositis

40

40

Injuries

50

50

Infectious complications after radio- and chemotherapy

60

60

Renal insufficiency

22

21

Cardiac insufficiency

50

50

Deep mycosis

30

30

Urinary tracts candidal infections

35

32

Respiratory tracts candidal infections

22

22

Herpetic lesions

180

180

Epstein-Barrs virus lesion

101

90

Chronic radiation disease opportunistic infections

83

83

Chronic obliterating arteries diseases

8

7

Varicocele

3

3

Thyrotoxicosis

5

3

Influenzal infection

537

537

Root bronchial pneumonia

3

3

Immunodeficit conditions

171

171

Pyelonephritis

20

16

Radical chronic immunodepression

35

32

Chronic pancreatitis

42

42

Cholecystitis

80

80

Varix dilatation

23

20

Layer aortic aneurysm

5

5

Morton's syndrome

8

7

Aortic aneurysm

12

12

Knee joint meniscus

187

187

Ischemic stroke

2

2

Biological aging (basic index is clinical laboratory research)

53

53

Thus preliminary data of "quantum SIM-medicines" implementation using transdermal injector show improvement in organism biochemical activity, faster remission achievement and autoimmune antibodies disappearance without any side effects. After finishing the quantum SIM-medisine therapy course alanine-aminotransferase activity reduces in average by 69% form the initial level, and in case with the patients who received only pharmaceuticals of similar effect it reduced only by 15%. The course lasted for 21 days. Using quantum SIM-medicine therapy improved general state, reduced weakness, raised the mood of the patients.

Quantum SIM-medicines effect duration was also checked. Especially significant are the observations of quantum medicines -INSULIN and -INSUMAN effect on the patients, sick with pancreatic diabetes. The check-up was made according to the indexed of glucose amount in blood, both by the method of biochemical analysis and using conventional glucometer test. Medicine -INSULIN effect duration was 24-36 hours, and that of medicine -INSUMAN was 36-72 hours. At the same time the effect duration of quantum SIM-medicines was also checked: -V ZAPROSTAN - 48 hours, -GRANOCYTE - 72 hours, -ZOVIR - 86 hours (individually according to specific perceptions in the areas of herpetic precipitation), -VOLTAREN - 12-36 hours (according to individual estimates).

The carries out preliminary clinical tests showed, that "quantum SIM-medicines" differ from pharmaceuticals generally accepted in the medical practice in the following ways:

  • The opportunity to exclude medical errors,
  • Absence of side effects,
  • Safety in using,
  • Uninvasive insertion method,
  • High rate and effectiveness in reaching therapeutic effect in a wide range of deseases,
  • Long effect duration.

"Quantum SIM-medicines" are distinguished for simple intake procedure. The effect of "quantum SIM-medicine" appears as a rule in a few minutes, irrespective of the age group of the patient.

Quantum medicines safely interact with each other and with any other pharmaceutical forms, at the same time reducing the side effects of the latter. They are an effective addition to the conventional therapy and enable the doctor to significantly reduce the doses and prescribed terms of many medicines intake, wich are often toxic and expensive.


©Attosoft 2007-2008. All rights reserved. At use of materials the reference to a site is obligatory